Ownership history in UBS Group AG · 5 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in SYNAPTOGENIX INC (SNPX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 16,609 | +14,282 | +613.8% | 0.00% | $109K | — |
| 2025 Q1 | REDUCED | 2,327 | -911 | -28.1% | 0.00% | $6K | — |
| 2024 Q4 | ADDED | 3,238 | +2,151 | +197.9% | 0.00% | $11K | — |
| 2024 Q3 | REDUCED | 1,087 | -966 | -47.1% | 0.00% | $3K | — |
| 2024 Q2 | INITIATED | 2,053 | — | — | 0.00% | $8K | — |
As of 2025 Q4 — sorted by position size